Style | Citing Format |
---|---|
MLA | Iraji F, et al.. "Efficacy of Mesotherapy With Tranexamic Acid and Ascorbic Acid With and Without Glutathione in Treatment of Melasma: A Split Face Comparative Trial." Journal of Cosmetic Dermatology, vol. 18, no. 5, 2019, pp. 1416-1421. |
APA | Iraji F, Nasimi M, Asilian A, Faghihi G, Mozafarpoor S, Hafezi H (2019). Efficacy of Mesotherapy With Tranexamic Acid and Ascorbic Acid With and Without Glutathione in Treatment of Melasma: A Split Face Comparative Trial. Journal of Cosmetic Dermatology, 18(5), 1416-1421. |
Chicago | Iraji F, Nasimi M, Asilian A, Faghihi G, Mozafarpoor S, Hafezi H. "Efficacy of Mesotherapy With Tranexamic Acid and Ascorbic Acid With and Without Glutathione in Treatment of Melasma: A Split Face Comparative Trial." Journal of Cosmetic Dermatology 18, no. 5 (2019): 1416-1421. |
Harvard | Iraji F et al. (2019) 'Efficacy of Mesotherapy With Tranexamic Acid and Ascorbic Acid With and Without Glutathione in Treatment of Melasma: A Split Face Comparative Trial', Journal of Cosmetic Dermatology, 18(5), pp. 1416-1421. |
Vancouver | Iraji F, Nasimi M, Asilian A, Faghihi G, Mozafarpoor S, Hafezi H. Efficacy of Mesotherapy With Tranexamic Acid and Ascorbic Acid With and Without Glutathione in Treatment of Melasma: A Split Face Comparative Trial. Journal of Cosmetic Dermatology. 2019;18(5):1416-1421. |
BibTex | @article{ author = {Iraji F and Nasimi M and Asilian A and Faghihi G and Mozafarpoor S and Hafezi H}, title = {Efficacy of Mesotherapy With Tranexamic Acid and Ascorbic Acid With and Without Glutathione in Treatment of Melasma: A Split Face Comparative Trial}, journal = {Journal of Cosmetic Dermatology}, volume = {18}, number = {5}, pages = {1416-1421}, year = {2019} } |
RIS | TY - JOUR AU - Iraji F AU - Nasimi M AU - Asilian A AU - Faghihi G AU - Mozafarpoor S AU - Hafezi H TI - Efficacy of Mesotherapy With Tranexamic Acid and Ascorbic Acid With and Without Glutathione in Treatment of Melasma: A Split Face Comparative Trial JO - Journal of Cosmetic Dermatology VL - 18 IS - 5 SP - 1416 EP - 1421 PY - 2019 ER - |